Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Biological Sciences, University of Limerick, Limerick, Ireland; Instituto de Ciencias Biomédicas, Universidad Autónoma de Chile, Santiago, Chile.
Int J Pharm. 2020 Jul 30;585:119476. doi: 10.1016/j.ijpharm.2020.119476. Epub 2020 May 27.
Neurodegenerative diseases are a major global public health concern in the elderly population but therapeutic options are limited. Curcumin is a hydrophobic polyphenol extracted from the dried rhizomes of Curcuma longa L. and shows good potential for the treatment of neurodegenerative diseases and brain tumors. The blood-brain barrier (BBB) is the major obstacle for the delivery of curcumin into the brain, limiting its therapeutic potential. The development of promising approaches to facilitate curcumin transportation across the BBB may resolve some of the problems associated with drug delivery. Studies have shown nano delivery of curcumin can improve a number of outcome measures in neurodegenerative diseases. The present review highlights current and emerging strategies to facilitate curcumin permeation across the BBB for the treatment of various neurodegenerative diseases.
神经退行性疾病是老年人群体中一个主要的全球公共卫生关注点,但治疗选择有限。姜黄素是一种从姜黄干燥根茎中提取的疏水性多酚,显示出治疗神经退行性疾病和脑肿瘤的良好潜力。血脑屏障 (BBB) 是姜黄素进入大脑的主要障碍,限制了其治疗潜力。开发有前途的方法来促进姜黄素穿过 BBB 的运输可能会解决与药物输送相关的一些问题。研究表明,姜黄素的纳米递药可以改善神经退行性疾病中的许多预后指标。本综述重点介绍了当前和新兴的策略,以促进姜黄素穿过 BBB 的渗透,从而治疗各种神经退行性疾病。